Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors
A series of new Olaparib derivatives was designed and synthesized, and their inhibitory activities against poly (ADP-ribose) polymerases-1 (PARP-1) enzyme and cancer cell line MDA-MB-436 in vitro were evaluated. The results showed that compound 5l exhibited the most potent inhibitory effects on PARP...
Main Authors: | Cheng-Zhi Gao, Wei Dong, Zhi-Wen Cui, Qiong Yuan, Xia-Min Hu, Qing-Ming Wu, Xianlin Han, Yao Xu, Zhen-Li Min |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14756366.2018.1530224 |
Similar Items
-
OLAPARIB: A promising PARP Inhibitor for the treatment of ovarian cancer
by: Soupos Nikolaos, et al.
Published: (2015-09-01) -
Honeys as Possible Sources of Cholinesterase Inhibitors
by: Dominik Szwajgier, et al.
Published: (2022-07-01) -
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma
by: Chung Ying Chan, et al.
Published: (2022-10-01) -
Vitamin B3-Based Biologically Active Compounds as Inhibitors of Human Cholinesterases
by: Antonio Zandona, et al.
Published: (2020-10-01) -
BASELINE PLASMA CHOLINESTERASE ACTIVITIES IN ARGENTINE SADDLE HORSES FROM SABANA DE BOGOTÁ
by: C. Ariza, et al.
Published: (2012-01-01)